Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study
Clinical trial NCT05645536 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05645536
- Sponsor
- Tolmar Inc.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-28
- Primary completion
- 2028-06-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.